These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 31639011)
41. Cerebrospinal Fluid Calbindin D Concentration as a Biomarker of Cerebellar Disease Progression in Niemann-Pick Type C1 Disease. Bradbury A; Bagel J; Sampson M; Farhat N; Ding W; Swain G; Prociuk M; O'Donnell P; Drobatz K; Gurda B; Wassif C; Remaley A; Porter F; Vite C J Pharmacol Exp Ther; 2016 Aug; 358(2):254-61. PubMed ID: 27307499 [TBL] [Abstract][Full Text] [Related]
42. Molecular Mind Games: The Medicinal Action of Cyclodextrins in Neurodegenerative Diseases. Braga SS Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189413 [TBL] [Abstract][Full Text] [Related]
43. Cyclodextrins applied to the treatment of lysosomal storage disorders. Ishitsuka Y; Irie T; Matsuo M Adv Drug Deliv Rev; 2022 Dec; 191():114617. PubMed ID: 36356931 [TBL] [Abstract][Full Text] [Related]
46. Efficacy of 2-Hydroxypropyl-β-cyclodextrin in Niemann-Pick Disease Type C Model Mice and Its Pharmacokinetic Analysis in a Patient with the Disease. Tanaka Y; Yamada Y; Ishitsuka Y; Matsuo M; Shiraishi K; Wada K; Uchio Y; Kondo Y; Takeo T; Nakagata N; Higashi T; Motoyama K; Arima H; Mochinaga S; Higaki K; Ohno K; Irie T Biol Pharm Bull; 2015; 38(6):844-51. PubMed ID: 26027824 [TBL] [Abstract][Full Text] [Related]
47. In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β-Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C. Yasmin N; Ishitsuka Y; Fukaura M; Yamada Y; Nakahara S; Ishii A; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Okada Y; Nishikawa J; Ichikawa A; Iohara D; Hirayama F; Higaki K; Ohno K; Matsuo M; Irie T Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845767 [TBL] [Abstract][Full Text] [Related]
48. Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 disease. Ottinger EA; Kao ML; Carrillo-Carrasco N; Yanjanin N; Shankar RK; Janssen M; Brewster M; Scott I; Xu X; Cradock J; Terse P; Dehdashti SJ; Marugan J; Zheng W; Portilla L; Hubbs A; Pavan WJ; Heiss J; Vite CH; Walkley SU; Ory DS; Silber SA; Porter FD; Austin CP; McKew JC Curr Top Med Chem; 2014; 14(3):330-9. PubMed ID: 24283970 [TBL] [Abstract][Full Text] [Related]
49. Low Risk Profile of Long-Term Repeated Lumbar Puncture for Intrathecal Delivery of 2-Hydroxypropyl-Beta-Cyclodextrin in Patients With Niemann-Pick Type C. Albert OK; Friedmann K; Jaeger R; Berry-Kravis E Pediatr Neurol; 2023 Jul; 144():99-103. PubMed ID: 37201244 [TBL] [Abstract][Full Text] [Related]
54. Niemann-Pick disease type C presenting as very early onset inflammatory bowel disease. Dike CR; Bernat J; Bishop W; DeGeeter C BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31352388 [TBL] [Abstract][Full Text] [Related]
55. Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells. Rosenbaum AI; Zhang G; Warren JD; Maxfield FR Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5477-82. PubMed ID: 20212119 [TBL] [Abstract][Full Text] [Related]
56. Predicting the Binding Mode of 2-Hydroxypropyl-β-cyclodextrin to Cholesterol by Means of the MD Simulation and the 3D-RISM-KH Theory. Hayashino Y; Sugita M; Arima H; Irie T; Kikuchi T; Hirata F J Phys Chem B; 2018 May; 122(21):5716-5725. PubMed ID: 29534570 [TBL] [Abstract][Full Text] [Related]
57. Co-treatment with probucol does not improve lung pathology in hydroxypropyl-β-cyclodextrin-treated Npc1 Erickson RP; Borbon IA J Appl Genet; 2019 May; 60(2):175-178. PubMed ID: 30815842 [TBL] [Abstract][Full Text] [Related]
58. Hydroxypropyl-β-cyclodextrin causes massive damage to the developing auditory and vestibular system. Ding D; Manohar S; Jiang H; Salvi R Hear Res; 2020 Oct; 396():108073. PubMed ID: 32956992 [TBL] [Abstract][Full Text] [Related]
59. Pluronic based β-cyclodextrin polyrotaxanes for treatment of Niemann-Pick Type C disease. Collins CJ; Loren BP; Alam MS; Mondjinou Y; Skulsky JL; Chaplain CR; Haldar K; Thompson DH Sci Rep; 2017 Apr; 7():46737. PubMed ID: 28452365 [TBL] [Abstract][Full Text] [Related]
60. Intracerebroventricular 2-hydroxypropyl-γ-cyclodextrin alleviates hepatic manifestations without distributing to the liver in a murine model of Niemann-Pick disease type C. Yamada Y; Ishitsuka Y; Fukaura-Nishizawa M; Kawata T; Ishii A; Shirakawa A; Sakai T; Tanaka M; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Arima H; Seki T; Kurauchi Y; Katsuki H; Higaki K; Ikeda R; Matsuo M; Era T; Irie T Life Sci; 2024 Aug; 350():122776. PubMed ID: 38852794 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]